| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.43 | 0.03 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.38 | 0.03 |